Cargando…
Considering the harms of our habits: The reflexive urine drug screen in opioid use disorder treatment
The COVID-19 pandemic has led to abrupt changes in the delivery of substance use treatment, notably the adoption of telehealth services and a departure from mandatory urine drug screens (UDS). Amid current circumstances, the UDS, which had evolved to signal a “successful” recovery, no longer seems f...
Autores principales: | Khatri, Utsha G., Aronowitz, Shoshana V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759699/ https://www.ncbi.nlm.nih.gov/pubmed/33358617 http://dx.doi.org/10.1016/j.jsat.2020.108258 |
Ejemplares similares
-
Urine Drug Screening in a Telehealth Setting for the Treatment of Opioid Use Disorder
por: Williams, Arthur Robin, et al.
Publicado: (2023) -
A Virtual-First Telehealth Treatment Model for Opioid Use Disorder
por: Williams, Arthur Robin, et al.
Publicado: (2022) -
Incidence of Treatment for Opioid Use Disorder Following Nonfatal Overdose in Commercially Insured Patients
por: Kilaru, Austin S., et al.
Publicado: (2020) -
A Brief Educational Intervention to Increase ED Initiation of Buprenorphine for Opioid Use Disorder (OUD)
por: Khatri, Utsha G., et al.
Publicado: (2022) -
Acute pain and self-directed discharge among hospitalized patients with opioid-related diagnoses: a cohort study
por: Compton, Peggy, et al.
Publicado: (2021)